COPD and Asthma Diagnostic and Monitoring Devices Market by Product (Diagnostic Devices, Monitoring Devices, and Consumables & Accessories), Indication (COPD and Asthma), and End User (Hospitals & Clinics, Homecare Settings, and Others): Global Opportunity Analysis and Industry Forecast, 2020–2027

March 2021 | 268 pages | ID: CE56DDE135F0EN
Allied Market Research

Abstracts

The global COPD and asthma diagnostic and monitoring device market accounted for $4,953.60 million in 2019, and is expected to reach $8,202.62 million by 2027, registering a CAGR of 6.3% from 2020 to 2027.

Rise in lifestyle habits such as smoking & consumption of alcohol and growth in geriatric population are expected to boost the market growth. In addition, technological advances for new devices, regulatory approvals, and product launches are further promoting the market growth. In addition, prevalence of air pollution, climate changes, and dust fuels the market growth. Moreover, prevalence of respiratory diseases is increasing across the globe. In 2017, according to the WHO, respiratory diseases were considered to be the leading causes of death and disability in the world. Nearly 65 million people suffer from COPD and 3 million are expected to die from it each year, making it the third leading cause of death across the globe.

Moreover, approximately 334 million people suffer from asthma, the most common chronic disease of childhood, affecting 14% of all children globally. Rise in disposable income and increase in healthcare investments by governments & private organizations are anticipated to propel the market growth.

Factors such as rise in prevalence of respiratory diseases, huge demand for enhanced portable devices, growth in geriatric population, and high prevalence of tobacco smoking are expected to drive the market growth during the forecast period. The market is witnessing the emerging trend for spirometers, electrocardiogram, peak flow meter, polysomnography devices, and arterial blood gas analyzer, which is helping in providing real-time monitoring.

The global COPD and asthma diagnostics and monitoring devices market is segmented on the basis of product, indication, end user, and region. Based on the product, the market is segmented into diagnostic devices, monitoring devices, and consumables and accessories. Furthermore, the diagnostic devices segment includes spirometers electrocardiogram, FeNo test analyzer, peak flow meter, arterial blood gas analyzer (ABG), polysomnography devices, and others. The monitoring devices segment includes pulse oximeters, capnograph, asthma monitors, portable table top pulse oximeter, wearable devices, Fourier transform infrared spectroscopy (FTIR), and others. The consumables and accessories segment includes masks, spirometry accessories, polysomnography accessories, peak flow meter accessories, pulse oximeter sensors, capnography accessories, gas analyzer accessories, and others. Based on indication, the market is divided into asthma and COPD. Based on end user, it is segregated into hospitals & clinics, home care settings, and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. These regions are further analyzed on the basis of respective countries.

The key players operating in the global COPD and asthma diagnostic and monitoring device market include Becton Dickinson and Company, Drдgerwerk AG & CO. KGAA, Getinge AB, Invacare Corporation, Masimo Corporation, Medtronic Plc, Koninklijke Philips N.V, Nihon Kohden Corporation, Smiths Medical, and Vyaire Medical INC.

KEY BENEFITS FOR STAKEHOLDERS

• The study provides an in-depth analysis of the global COPD and asthma diagnostics and monitoring devices market along with the current trends and future estimations to elucidate the imminent investment pockets.
• Comprehensive analysis of factors that drive and restrict the market growth is provided in the report.
• Comprehensive quantitative analysis of the industry from 2019 to 2027 is provided to enable the stakeholders to capitalize on the prevailing market opportunities.
• Extensive analysis of the key segments of the industry helps in understanding the forms and types of cell therapy used across the globe.
• Key market players and their strategies have been analyzed to understand the competitive outlook of the market.

KEY MARKET SEGMENTS

By Product Type

• Diagnostic Devices
• Spirometers
• Electrocardiogram
• FeNo Test Analyzer
• Peak Flow Meter
• Arterial Blood Gas Analyzer (ABG)
• Polysomnography Devices
• Others
• Monitoring Devices
• Pulse Oximeters
• Capnograph
• Asthma Monitors
• Portable Table Top Pulse Oximeter
• Wearable Devices
• Fourier Transform Infrared Spectroscopy (FTIR)
• Others
• Consumables and Accessories
• Masks
• Spirometry Accessories
• Polysomnography Accessories
• Peak Flow Meter Accessories
• Pulse Oximeter Sensors
• Capnography Accessories
• Gas Analyzer Accessories
• Others

By Indication

• COPD
• Asthma

By End User

• Hospitals and Clinics
• Home Care Settings
• Others

By Region

North America

• U.S.
• Canada
• Mexico

Europe

• Germany
• UK
• France
• Italy
• Spain
• Rest of Europe

Asia-Pacific

• Japan
• China
• India
• Australia
• South Korea
• Rest of Asia-Pacific

LAMEA

• Brazil
• Saudi Arabia
• South Africa
• Rest of LAMEA

LIST OF KEY PLAYERS PROFILED IN THE REPORT

• Becton Dickinson And Company
• Drдgerwerk AG & CO. KGAA
• Getinge AB
• Invacare Corporation
• Masimo Corporation
• Medtronic PLC
• Koninklijke Philips N.V
• Nihon Kohden Corporation
• Smiths Medical
• Vyaire Medical INC.

Contents

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key market segments
1.3.List of key players profiled in the report
1.4.Research methodology
  1.4.1.Primary research
  1.4.2.Secondary research
  1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
  3.1.1.Top winning strategies, 2019
3.2.Top player positioning
  3.2.1.Top investment pockets
3.3.Key forces shaping global COPD and asthma diagnostic and monitoring device market industry/market
3.4.Market dynamics
  3.4.1.Drivers
    3.4.1.1.Daily exposure to environmental pollution
    3.4.1.2.Increase in population susceptible to indoor air pollutants
    3.4.1.3.Portability of the drug delivery devices
    3.4.1.4.Increase in population of active smokers
    3.4.1.5.Growth in number of surgeries
  3.4.2.Restraints
    3.4.2.1.High costs of the device
    3.4.2.2.Stringent regulatory procedures
  3.4.3.Opportunities
    3.4.3.1.High growth potential in emerging markets
    3.4.3.2.Increase in geriatric population
  3.4.4.Impact analysis
3.5.COVID-19 impact analysis for the COPD and asthma diagnostic and monitoring device market
3.6.Volume and average sales price analysis of India and China of COPD and asthma diagnostic and monitoring device market

CHAPTER 4:COPD AND ASTHMA DIAGNOSTIC AND MONITORING

DEVICES MARKET, BY PRODUCT
4.1.Overview
  4.1.1.Market size and forecast
4.2.Diagnostic devices
  4.2.1.Key market trends, growth factors, and opportunities
  4.2.2.Market size and forecast
  4.2.3.Market share analysis, by country
    4.2.3.1.Market size and forecast, by type
    4.2.3.2.Spirometers
    4.2.3.3.Market size and forecast
    4.2.3.4.Electrocardiogram
    4.2.3.5.Market size and forecast
    4.2.3.6.FeNo test analyzer
    4.2.3.7.Market size and forecast
    4.2.3.8.Arterial blood gas analyzer (ABG)
    4.2.3.9.Market size and forecast
    4.2.3.10.Polysomnography devices
    4.2.3.11.Market size and forecast
    4.2.3.12.Peak flow meters
    4.2.3.13.Market size and forecast
    4.2.3.14.Others
    4.2.3.15.Market size and forecast
4.3.Monitoring devices
  4.3.1.Key market trends, growth factors, and opportunities
  4.3.2.Market size and forecast
  4.3.3.Market share analysis, by country
    4.3.3.1.Market size and forecast, by type
    4.3.3.2.Pulse oximeters
    4.3.3.3.Market size and forecast
    4.3.3.4.Capnographs
    4.3.3.5.Market size and forecast
    4.3.3.6.Asthma monitors
    4.3.3.7.Market size and forecast
    4.3.3.8.Portable table top pulse oximeter
    4.3.3.9.Market size and forecast
    4.3.3.10.Wearable devices
    4.3.3.11.Market size and forecast
    4.3.3.12.Fourier transform infrared spectroscopy (FTIR)
    4.3.3.13.Market size and forecast
    4.3.3.14.Others
    4.3.3.15.Market size and forecast
4.4.Consumables and accessories
  4.4.1.Key market trends, growth factors, and opportunities
  4.4.2.Market size and forecast
  4.4.3.Market share analysis, by country
    4.4.3.1.Market size and forecast, by type
    4.4.3.2.Masks
    4.4.3.3.Market size and forecast
    4.4.3.4.Spirometry accessories
    4.4.3.5.Market size and forecast
    4.4.3.6.Polysomnography accessories
    4.4.3.7.Market size and forecast
    4.4.3.8.Peak flow meter accessories
    4.4.3.9.Market size and forecast
    4.4.3.10.Pulse oximeter sensors
    4.4.3.11.Market size and forecast
    4.4.3.12.Capnography accessories
    4.4.3.13.Market size and forecast
    4.4.3.14.Gas analyzer accessories
    4.4.3.15.Market size and forecast
    4.4.3.16.Others
    4.4.3.17.Market size and forecast

CHAPTER 5:COPD AND ASTHMA DIAGNOSTIC AND MONITORING

DEVICES MARKET, BY INDICATION
5.1.Overview
  5.1.1.Market size and forecast
5.2.Asthma
  5.2.1.Market size and forecast
  5.2.2.Market share analysis, by country
5.3.COPD
  5.3.1.Market size and forecast
  5.3.2.Market share analysis, by country

CHAPTER 6:COPD AND ASTHMA DIAGNOSTIC AND MONITORING

DEVICES MARKET, BY END USER
6.1.Overview
  6.1.1.Market size and forecast
6.2.Hospitals and clinics
  6.2.1.Market size and forecast
  6.2.2.Market share analysis, by country
6.3.Home care settings
  6.3.1.Market size and forecast
  6.3.2.Market share analysis, by country
6.4.Others
  6.4.1.Market size and forecast
  6.4.2.Market share analysis, by country

CHAPTER 7:COPD AND ASTHMA DIAGNOSTIC AND MONITORING

DEVICES MARKET, BY REGION
7.1.Overview
  7.1.1.Market size and forecast
7.2.North America
  7.2.1.Key market trends and opportunities
  7.2.2.North America market size and forecast, by country
  7.2.3.North America market size and forecast, by product
  7.2.4.North America market size and forecast, by indication
  7.2.5.North America market size and forecast, by end user
    7.2.5.1.U.S. market size and forecast
      7.2.5.1.1.Market size and forecast, by product
      7.2.5.1.2.Market size and forecast, by indication
      7.2.5.1.3.Market size and forecast, by end user
    7.2.5.3.Canada market size and forecast
      7.2.5.3.1.Market size and forecast, by product
      7.2.5.3.2.Market size and forecast, by indication
      7.2.5.3.3.Market size and forecast, by end user
    7.2.5.4.Mexico market size and forecast
      7.2.5.4.1.Market size and forecast, by product
      7.2.5.4.2.Market size and forecast, by indication
      7.2.5.4.3.Market size and forecast, by end user
7.3.Europe
  7.3.1.Key market trends and opportunities
  7.3.2.Europe market size and forecast, by country
  7.3.3.Europe market size and forecast, by product
  7.3.4.Europe market size and forecast, by indication
  7.3.5.Europe market size and forecast, by end user
    7.3.5.1.Germany market size and forecast
      7.3.5.1.1.Market size and forecast, by product
      7.3.5.1.2.Market size and forecast, by indication
      7.3.5.1.3.Market size and forecast, by end user
    7.3.5.2.France market size and forecast
      7.3.5.2.1.Market size and forecast, by product
      7.3.5.2.2.Market size and forecast, by indication
      7.3.5.2.3.Market size and forecast, by end user
    7.3.5.3.UK market size and forecast
      7.3.5.3.1.Market size and forecast, by product
      7.3.5.3.2.Market size and forecast, by indication
      7.3.5.3.3.Market size and forecast, by end user
    7.3.5.4.Italy market size and forecast
      7.3.5.4.1.Market size and forecast, by product
      7.3.5.4.2.Market size and forecast, by indication
      7.3.5.4.3.Market size and forecast, by end user
    7.3.5.5.Spain market size and forecast
      7.3.5.5.1.Market size and forecast, by product
      7.3.5.5.2.Market size and forecast, by indication
      7.3.5.5.3.Market size and forecast, by end user
    7.3.5.6.Rest of Europe market size and forecast
      7.3.5.6.1.Market size and forecast, by product
      7.3.5.6.2.Market size and forecast, by indication
      7.3.5.6.3.Market size and forecast, by end user
7.4.Asia-Pacific
  7.4.1.Key market trends and opportunities
  7.4.2.Asia-Pacific market size and forecast, by country
  7.4.3.Asia-Pacific market size and forecast, by product
  7.4.4.Asia-Pacific market size and forecast, by indication
  7.4.5.Asia-Pacific market size and forecast, by end user
    7.4.5.1.China market size and forecast
      7.4.5.1.1.Market size and forecast, by product
      7.4.5.1.2.Market size and forecast, by indication
      7.4.5.1.3.Market size and forecast, by end user
    7.4.5.2.Japan market size and forecast
      7.4.5.2.1.Market size and forecast, by product
      7.4.5.2.2.Market size and forecast, by indication
      7.4.5.2.3.Market size and forecast, by end user
    7.4.5.3.India market size and forecast
      7.4.5.3.1.Market size and forecast, by product
      7.4.5.3.2.Market size and forecast, by indication
      7.4.5.3.3.Market size and forecast, by end user
    7.4.5.4.Australia market size and forecast
      7.4.5.4.1.Market size and forecast, by product
      7.4.5.4.2.Market size and forecast, by indication
      7.4.5.4.3.Market size and forecast, by end user
    7.4.5.5.South Korea market size and forecast
      7.4.5.5.1.Market size and forecast, by product
      7.4.5.5.2.Market size and forecast, by indication
      7.4.5.5.3.Market size and forecast, by end user
    7.4.5.6.Rest of Asia-Pacific market size and forecast
      7.4.5.6.1.Market size and forecast, by product
      7.4.5.6.2.Market size and forecast, by indication
      7.4.5.6.3.Market size and forecast, by end user
7.5.LAMEA
  7.5.1.Key market trends and opportunities
  7.5.2.LAMEA market size and forecast, by country
  7.5.3.LAMEA market size and forecast, by product
  7.5.4.LAMEA market size and forecast, by indication
  7.5.5.LAMEA market size and forecast, by end user
    7.5.5.1.Brazil market size and forecast
      7.5.5.1.1.Market size and forecast, by product
      7.5.5.1.2.Market size and forecast, by indication
      7.5.5.1.3.Market size and forecast, by end user
    7.5.5.2.Saudi Arabia market size and forecast
      7.5.5.2.1.Market size and forecast, by product
      7.5.5.2.2.Market size and forecast, by indication
      7.5.5.2.3.Market size and forecast, by end user
    7.5.5.3.South Africa market size and forecast
      7.5.5.3.1.Market size and forecast, by product
      7.5.5.3.2.Market size and forecast, by indication
      7.5.5.3.3.Market size and forecast, by end user
    7.5.5.4.Rest of LAMEA market size and forecast
      7.5.5.4.1.Market size and forecast, by product
      7.5.5.4.2.Market size and forecast, by indication
      7.5.5.4.3.Market size and forecast, by end user

CHAPTER 8:COMPANY PROFILES

8.1.BECTON DICKINSON AND COMPANY
  8.1.1.Company overview
  8.1.2.Company snapshot
  8.1.3.Operating business segments
  8.1.4.Product portfolio
  8.1.5.Business performance
  8.1.6.Key strategic moves and developments
8.2.DRAGERWERK AG & CO. KGAA
  8.2.1.Company overview
  8.2.2.Company snapshot
  8.2.3.Operating business segments
  8.2.4.Product portfolio
  8.2.5.Business performance
  8.2.6.Key strategic moves and developments
8.3.GETINGE AB
  8.3.1.Company overview
  8.3.2.Company snapshot
  8.3.3.Operating business segments
  8.3.4.Product portfolio
  8.3.5.Business performance
  8.3.6.Key strategic moves and developments
8.4.INVACARE CORPORATION
  8.4.1.Company overview
  8.4.2.Company snapshot
  8.4.3.Operating business segments
  8.4.4.Product portfolio
  8.4.5.Business performance
8.5.MASIMO CORPORATION
  8.5.1.Company overview
  8.5.2.Company snapshot
  8.5.3.Operating business segments
  8.5.4.Product portfolio
  8.5.5.Business performance
  8.5.6.Key strategic moves and developments
8.6.MEDTRONIC PLC
  8.6.1.Company overview
  8.6.2.Operating business segments
  8.6.3.Product portfolio
  8.6.4.Business performance
8.7.NIHON KOHDEN CORPORATION
  8.7.1.Company overview
  8.7.2.Company snapshot
  8.7.3.Operating business segments
  8.7.4.Product portfolio
  8.7.5.Business performance
  8.7.6.Key strategic moves and developments
8.8.KONINKLIJKE PHILIPS N.V.
  8.8.1.Company overview
  8.8.2.Company snapshot
  8.8.3.Operating business segments
  8.8.4.Product portfolio
  8.8.5.Business performance
  8.8.6.Key strategic moves and developments
8.9.SMITHS MEDICAL
  8.9.1.Company overview
  8.9.2.Company snapshot
  8.9.3.Operating business segments
  8.9.4.Product portfolio
  8.9.5.Business performance
  8.9.6.Key strategic moves and developments
8.10.VYAIRE MEDICAL
  8.10.1.Company overview
  8.10.2.Company snapshot
  8.10.3.Operating business segments
  8.10.4.Product portfolio
  8.10.5.Key strategic moves and developments

List Of Tables

LIST OF TABLES

TABLE 01.COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET
TABLE 02.COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET
TABLE 03.COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY PRODUCT,
2019-2027 ($MILLION)
TABLE 04.DIAGNOSTIC DEVICES COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET,
BY REGION 2019-2027, ($MILLION)
TABLE 05.DIAGNOSTIC DEVICES COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY TYPE
2019-2027, ($MILLION)
TABLE 06.MONITORING DEVICES COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET,
BY REGION 2019-2027, ($MILLION)
TABLE 07.MONITORING DEVICES COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET,
BY TYPE 2019-2027, ($MILLION)
TABLE 08.CONSUMABLES AND ACCESSORIES COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES
MARKET, BY REGION 2019-2027, ($MILLION)
TABLE 09.CONSUMABLES AND ACCESSORIES COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES
MARKET, BY TYPE 2019-2027, ($MILLION)
TABLE 10.COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY INDICATION,
2019-2027 ($MILLION)
TABLE 11.ASTHMA COPD ANDS ASTHMA DEVICES MARKET, BY REGION, 2019-2027 ($MILLION)
TABLE 12.COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY REGION,
2019-2027 ($MILLION)
TABLE 13.COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY END USER,
2019-2027 ($MILLION)
TABLE 14.HOSPITALS AND CLINICS COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET,
BY REGION, 2019-2027 ($MILLION)
TABLE 15.HOME CARE SETTINGS COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET,
BY REGION, 2019-2027 ($MILLION)
TABLE 16.OTHERS COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY REGION,
2019-2027 ($MILLION)
TABLE 17.GLOBAL COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY REGION
2019-2027 ($MILLION)
TABLE 18.NORTH AMERICA COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET,
BY COUNTRY, 2019–2027 ($MILLION)
TABLE 19.NORTH AMERICA COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET,
BY PRODUCT, 2019–2027 ($MILLION)
TABLE 20.NORTH AMERICA COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET,
BY INDICATION, 2019–2027 ($MILLION)
TABLE 21.NORTH AMERICA COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET,
BY END USER, 2019–2027 ($MILLION)
TABLE 22.U.S. COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY PRODUCT,
2019–2027 ($MILLION)
TABLE 23.U.S. COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY INDICATION,
2019–2027 ($MILLION)
TABLE 24.U.S. COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY END USER,
2019–2027 ($MILLION)
TABLE 25.CANADA COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY PRODUCT,
2019–2027 ($MILLION)
TABLE 26.CANADA COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY INDICATION,
2019–2027 ($MILLION)
TABLE 27.CANADA COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY END USER,
2019–2027 ($MILLION)
TABLE 28.MEXICO COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY PRODUCT,
2019–2027 ($MILLION)
TABLE 29.MEXICO COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY INDICATION,
2019–2027 ($MILLION)
TABLE 30.MEXICO COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY END USER,
2019–2027 ($MILLION)
TABLE 31.EUROPE COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY COUNTRY,
2019–2027 ($MILLION)
TABLE 32.EUROPE COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY PRODUCT,
2019–2027 ($MILLION)
TABLE 33.EUROPE COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY INDICATION,
2019–2027 ($MILLION)
TABLE 34.EUROPE COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY END USER,
2019–2027 ($MILLION)
TABLE 35.GERMANY COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY PRODUCT,
2019–2027 ($MILLION)
TABLE 36.GERMANY COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY INDICATION,
2019–2027 ($MILLION)
TABLE 37.GERMANY COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY END USER,
2019–2027 ($MILLION)
TABLE 38.FRANCE COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY PRODUCT,
2019–2027 ($MILLION)
TABLE 39.FRANCE COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY INDICATION,
2019–2027 ($MILLION)
TABLE 40.FRANCE COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY END USER,
2019–2027 ($MILLION)
TABLE 41.UK COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY PRODUCT,
2019–2027 ($MILLION)
TABLE 42.UK COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY INDICATION,
2019–2027 ($MILLION)
TABLE 43.UK COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY END USER,
2019–2027 ($MILLION)
TABLE 44.ITALY COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY PRODUCT,
2019–2027 ($MILLION)
TABLE 45.ITALY COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY INDICATION,
2019–2027 ($MILLION)
TABLE 46.ITALY COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY END USER,
2019–2027 ($MILLION)
TABLE 47.SPAIN COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY PRODUCT,
2019–2027 ($MILLION)
TABLE 48.SPAIN COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY INDICATION,
2019–2027 ($MILLION)
TABLE 49.SPAIN COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY END USER,
2019–2027 ($MILLION)
TABLE 50.REST OF EUROPE COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET,
BY PRODUCT, 2019–2027 ($MILLION)
TABLE 51.REST OF EUROPE COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET,
BY INDICATION, 2019–2027 ($MILLION)
TABLE 52.REST OF EUROPE COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET,
BY END USER, 2019–2027 ($MILLION)
TABLE 53.ASIA-PACIFIC COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY COUNTRY,
2019–2027 ($MILLION)
TABLE 54.ASIA-PACIFIC COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY PRODUCT,
2019–2027 ($MILLION)
TABLE 55.ASIA-PACIFIC COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY INDICATION,
2019–2027 ($MILLION)
TABLE 56.ASIA-PACIFIC COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY END USER,
2019–2027 ($MILLION)
TABLE 57.CHINA COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY PRODUCT,
2019–2027 ($MILLION)
TABLE 58.CHINA COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY INDICATION,
2019–2027 ($MILLION)
TABLE 59.CHINA COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY END USER,
2019–2027 ($MILLION)
TABLE 60.JAPAN COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY PRODUCT,
2019–2027 ($MILLION)
TABLE 61.JAPAN COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY INDICATION,
2019–2027 ($MILLION)
TABLE 62.JAPAN COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY END USER,
2019–2027 ($MILLION)
TABLE 63.INDIA COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY PRODUCT,
2019–2027 ($MILLION)
TABLE 64.INDIA COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY INDICATION,
2019–2027 ($MILLION)
TABLE 65.INDIA COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY END USER,
2019–2027 ($MILLION)
TABLE 66.AUSTRALIA COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY PRODUCT,
2019–2027 ($MILLION)
TABLE 67.AUSTRALIA COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY INDICATION,
2019–2027 ($MILLION)
TABLE 68.AUSTRALIA COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY END USER,
2019–2027 ($MILLION)
TABLE 69.SOUTH KOREA COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY PRODUCT,
2019–2027 ($MILLION)
TABLE 70.SOUTH KOREA COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY INDICATION, 2019–2027 ($MILLION)
TABLE 71.SOUTH KOREA COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY END USER,
2019–2027 ($MILLION)
TABLE 72.REST OF ASIA-PACIFIC COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET,
BY PRODUCT, 2019–2027 ($MILLION)
TABLE 73.REST OF ASIA-PACIFIC COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET,
BY INDICATION, 2019–2027 ($MILLION)
TABLE 74.REST OF ASIA-PACIFIC COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET,
BY END USER, 2019–2027 ($MILLION)
TABLE 75.LAMEA COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY COUNTRY,
2019–2027 ($MILLION)
TABLE 76.LAMEA COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY PRODUCT,
2019–2027 ($MILLION)
TABLE 77.LAMEA COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY INDICATION,
2019–2027 ($MILLION)
TABLE 78.LAMEA COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY END USER,
2019–2027 ($MILLION)
TABLE 79.BRAZIL COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY PRODUCT,
2019–2027 ($MILLION)
TABLE 80.BRAZIL COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY INDICATION,
2019–2027 ($MILLION)
TABLE 81.BRAZIL COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY END USER,
2019–2027 ($MILLION)
TABLE 82.SAUDI ARABIA COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY PRODUCT,
2019–2027 ($MILLION)
TABLE 83.SAUDI ARABIA COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY INDICATION, 2019–2027 ($MILLION)
TABLE 84.SAUDI ARABIA COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY END USER,
2019–2027 ($MILLION)
TABLE 85.SOUTH AFRICA COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY PRODUCT,
2019–2027 ($MILLION)
TABLE 86.SOUTH AFRICA COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET,
BY INDICATION, 2019–2027 ($MILLION)
TABLE 87.SOUTH AFRICA COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY END USER,
2019–2027 ($MILLION)
TABLE 88.REST OF LAMEA COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET,
BY PRODUCT, 2019–2027 ($MILLION)
TABLE 89.REST OF LAMEA COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET,
BY INDICATION, 2019–2027 ($MILLION)
TABLE 90.REST OF LAMEA COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET,
BY END USER, 2019–2027 ($MILLION)
TABLE 91.BD: COMPANY SNAPSHOT
TABLE 92.BD: OERATING SEGMENT
TABLE 93.BD: PRODUCT PORTFOLIO
TABLE 94.DRAGER: COMPANY SNAPSHOT
TABLE 95.DRAGER: OERATING SEGMENT
TABLE 96.DRAGER: PRODUCT PORTFOLIO
TABLE 97.GETINGE: COMPANY SNAPSHOT
TABLE 98.GETINGE: OERATING SEGMENT
TABLE 99.GETINGE: PRODUCT PORTFOLIO
TABLE 100.INVACARE CORPORATION: COMPANY SNAPSHOT
TABLE 101.INVACARE CORPORATION: OERATING SEGMENT
TABLE 102.INVACARE CORPORATION: PRODUCT PORTFOLIO
TABLE 103.MASIMO: COMPANY SNAPSHOT
TABLE 104.MASIMO: OERATING SEGMENT
TABLE 105.MASIMO: PRODUCT PORTFOLIO
TABLE 106.MEDTRONIC: COMPANY SNAPSHOT
TABLE 107.MEDTRONIC: OERATING SEGMENT
TABLE 108.MEDTRONIC: PRODUCT PORTFOLIO
TABLE 109.NIHON KOHDEN: COMPANY SNAPSHOT
TABLE 110.NIHON KOHDEN: OERATING SEGMENT
TABLE 111.NIHON KOHDEN: PRODUCT PORTFOLIO
TABLE 112.PHILIPS.: COMPANY SNAPSHOT
TABLE 113.PHILIPS.: OERATING SEGMENT
TABLE 114.PHILIPS.: PRODUCT PORTFOLIO
TABLE 115.SMITHS MEDICAL: COMPANY SNAPSHOT
TABLE 116.SMITHS MEDICAL: OERATING SEGMENT
TABLE 117.SMITHS MEDICAL: PRODUCT PORTFOLIO
TABLE 118.VYAIRE MEDICAL: COMPANY SNAPSHOT
TABLE 119.VYAIRE MEDICAL: OERATING SEGMENT
TABLE 120.VYAIRE MEDICAL: PRODUCT PORTFOLIO

List Of Figures

LIST OF FIGURES

FIGURE 01.COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICE MARKET SEGMENTATION
FIGURE 02.TOP WINNING STRATEGIES, BY DEVELOPMENTS, 2017–2021*
FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2017–2021*
FIGURE 04.TOP WINNING STRATEGIES: COMPANY, 2017–2021
FIGURE 05.TOP PLAYER POSITIONING, 2019
FIGURE 06.TOP INVESTMENT POCKETS
FIGURE 07.MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 08.MODERATE BARGAINING POWER OF BUYERS
FIGURE 09.MODERATE THREAT OF SUBSTITUTES
FIGURE 10.MODERATE INTENSITY OF RIVALRY
FIGURE 11.HIGH THREAT OF NEW ENTRANTS
FIGURE 12.IMPACT ANALYSIS, COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICE MARKET
FIGURE 13.COMPARATIVE SHARE ANALYSIS OF DIAGNOSTIC DEVICES COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY COUNTRY, 2019 & 2027(%)
FIGURE 14.GLOBAL SPIROMETERS MARKET, 2019–2027 ($MILLION)
FIGURE 15.GLOBAL ELECTROCARDIOGRAM MARKET, 2019–2027 ($MILLION)
FIGURE 16.GLOBAL FENO TEST ANALYZER MARKET, 2019–2027 ($MILLION)
FIGURE 17.GLOBAL ARTERIAL BLOOD GAS ANALYZER (ABG) MARKET, 2019–2027 ($MILLION)
FIGURE 18.GLOBAL POLYSOMNOGRAPHY DEVICES MARKET, 2019–2027 ($MILLION)
FIGURE 19.GLOBAL PEAK FLOW METERS MARKET, 2019–2027 ($MILLION)
FIGURE 20.GLOBAL OTHERS MARKET, 2019–2027 ($MILLION)
FIGURE 21.COMPARATIVE SHARE ANALYSIS OF MONITORING DEVICES COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY COUNTRY, 2019 & 2027(%)
FIGURE 22.GLOBAL PULSE OXIMETERS MARKET, 2019–2027 ($MILLION)
FIGURE 23.GLOBAL CAPNOGRAPHS MARKET, 2019–2027 ($MILLION)
FIGURE 24.GLOBAL ASTHMA MONITORS MARKET, 2019–2027 ($MILLION)
FIGURE 25.GLOBAL PORTABLE TABLE TOP PULSE OXIMETER MARKET, 2019–2027 ($MILLION)
FIGURE 26.GLOBAL WEARABLE DEVICESMARKET, 2019–2027 ($MILLION)
FIGURE 27.GLOBAL FOURIER TRANSFORM INFRARED SPECTROSCOPY (FTIR) MARKET, 2019–2027 ($MILLION)
FIGURE 28.GLOBAL OTHERS MARKET, 2019–2027 ($MILLION)
FIGURE 29.COMPARATIVE SHARE ANALYSIS OF CONSUMABLES AND ACCESSORIES COPD AND ASTHMA
DIAGNOSTIC AND MONITORING DEVICES MARKET, BY COUNTRY, 2019 & 2027(%)
FIGURE 30.GLOBAL MASKS MARKET, 2019–2027 ($MILLION)
FIGURE 31.GLOBAL SPIROMETRY ACCESSORIES MARKET, 2019–2027 ($MILLION)
FIGURE 32.GLOBAL POLYSOMNOGRAPHY ACCESSORIES MARKET, 2019–2027 ($MILLION)
FIGURE 33.GLOBAL PEAK FLOW METER ACCESSORIES MARKET, 2019–2027 ($MILLION)
FIGURE 34.GLOBAL PULSE OXIMETER SENSORSMARKET, 2019–2027 ($MILLION)
FIGURE 35.GLOBAL CAPNOGRAPHY ACCESSORIES MARKET, 2019–2027 ($MILLION)
FIGURE 36.GLOBAL GAS ANALYZER ACCESSORIESMARKET, 2019–2027 ($MILLION)
FIGURE 37.GLOBAL OTHERS MARKET, 2019–2027 ($MILLION)
FIGURE 38.COMPARATIVE SHARE ANALYSIS OF ASTHMA COPD AND ASTHMA DIAGNOSTIC AND MONITORING
DEVICES MARKET, BY COUNTRY, 2019 & 2027(%)
FIGURE 39.COMPARATIVE SHARE ANALYSIS OF COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES
MARKET, BY COUNTRY, 2019 & 2027(%)
FIGURE 40.COMPARATIVE SHARE ANALYSIS OF HOSPITALS AND CLINICS COPD AND ASTHMA DIAGNOSTIC
AND MONITORING DEVICES MARKET, BY COUNTRY, 2019 & 2027(%)
FIGURE 41.COMPARATIVE SHARE ANALYSIS OF HOME CARE SETTINGS COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY COUNTRY, 2019 & 2027(%)
FIGURE 42.COMPARATIVE SHARE ANALYSIS OF OTHERS COPD AND ASTHMA DIAGNOSTIC AND MONITORING
DEVICES MARKET, BY COUNTRY, 2019 & 2027(%)
FIGURE 43.BD: NET SALES, 2018–2020 ($MILLION)
FIGURE 44.BD: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 45.BD: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 46.DRAGER: NET SALES, 2017–2019 ($MILLION)
FIGURE 47.DRAGER: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 48.DRAGER: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 49.GETINGE: NET SALES, 2017–2019 ($MILLION)
FIGURE 50.GETINGE: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 51.GETINGE: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 52.INVACARE CORPORATION: NET SALES, 2017–2019 ($MILLION)
FIGURE 53.INVACARE CORPORATION: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 54.INVACARE CORPORATION: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 55.MASIMO: NET SALES, 2017–2019 ($MILLION)
FIGURE 56.MEDTRONIC: NET SALES, 2018–2020 ($MILLION)
FIGURE 57.MEDTRONIC: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 58.MEDTRONIC: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 59.NIHON KOHDEN: NET SALES, 2017–2019 ($MILLION)
FIGURE 60.NIHON KOHDEN: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 61.PHILIPS.: NET SALES, 2018–2020 ($MILLION)
FIGURE 62.PHILIPS: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 63.PHILIPS: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 64.SMITHS MEDICAL: NET SALES, 2019–2020 ($MILLION)
FIGURE 65.SMITHS MEDICAL: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 66.SMITHS MEDICAL: REVENUE SHARE, BY REGION, 2020 (%)